AATK Antikörper (AA 1039-1207)
Kurzübersicht für AATK Antikörper (AA 1039-1207) (ABIN2203309)
Target
Alle AATK Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 1039-1207
-
Kreuzreaktivität
- Human
-
Kreuzreaktivität (Details)
- Calculated cross reactivity: Hu
-
Produktmerkmale
- Apoptosis-Associated Tyrosine Kinase (AATK)
-
Aufreinigung
- Purified by Protein G affinity chromatography.
-
Immunogen
- E. coli-derived rhAATK. (aa 1039 - 1207)
-
Isotyp
- IgG2b
-
-
anti-Apoptosis-Associated tyrosine Kinase (AATK) (AA 1216-1374) antibody
AATK Reaktivität: Human IHC, WB, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Apoptosis-Associated tyrosine Kinase (AATK) (AA 161-260) antibodyAATK Reaktivität: Human ELISA, WB, IHC (p) Wirt: Maus Monoclonal 5B8 unconjugated
anti-Apoptosis-Associated tyrosine Kinase (AATK) antibodyAATK Reaktivität: Human, Maus ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Apoptosis-Associated tyrosine Kinase (AATK) (AA 137-386) antibodyAATK Reaktivität: Maus IHC, WB, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Apoptosis-Associated tyrosine Kinase (AATK) (AA 55-90) antibodyAATK Reaktivität: Human, Maus WB Wirt: Kaninchen Polyclonal RB53015 unconjugated
anti-Apoptosis-Associated tyrosine Kinase (AATK) (AA 46-74), (N-Term) antibodyAATK Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
-
-
Applikationshinweise
- Optimal working conditions should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Reconstitute with 200 μL sterile 40-50 % glycerol, PBS.
-
Buffer
- Supplied as a lyophilized powder in PBS, 5 % trehalose.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- -20°C
-
-
- AATK (Apoptosis-Associated tyrosine Kinase (AATK))
-
Andere Bezeichnung
- Apoptosis-Associated Tyrosine Kinase
-
Pathways
- RTK Signalweg, Regulation of Cell Size
Target
-
